These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Clinical study on effect of kang' aibao oral liquid in treating 103 malignant tumor patients].
    Author: Wang HZ, Lin ZT.
    Journal: Zhongguo Zhong Xi Yi Jie He Za Zhi; 1997 Dec; 17(12):730-2. PubMed ID: 10322821.
    Abstract:
    OBJECTIVE: To observe the clinical efficacy of Kangaibao oral liquid(KABOL), a Chinese herbal preparation in treating malignant turmor of middle or advanced stage. METHODS: A comparative study was done by observing the effect of 103 patients treated with KABOL, and another 90 patients treated with chemotherapy in the same period were taken as a control group for comparison. RESULTS: The immunologic function, short-term effective rate (complete relieved rate and partial relieved rate), survival quality, 1-, 2- and 3-year survival rate, median suvival time, and the CEA declining rate of the KABOL group were significantly higher than those of the control group. CONCLUSIONS: KABOL has the effects of inhibiting tumor growth, prolonging the survival time and improving the quality of survival of tumor patient.
    [Abstract] [Full Text] [Related] [New Search]